Inflammatory bowel disease biologic blunts immune response to COVID-19, study finds
![Inflammatory bowel disease biologic blunts immune response to COVID-19, study finds](https://crohnsfighters.com/wp-content/uploads/2023/02/scidaily-logo-rss.png)
Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response to COVID-19 infection, new research indicates.